Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMPMedica was a leading global provider of healthcare information, medical publishing, and continuing medical education (CME) services. The company specialized in delivering clinical reference tools, professional journals, and digital platforms to support healthcare professionals in clinical decision-making and professional development. Its portfolio included highly recognized brands such as MIMS (Monthly Index of Medical Specialities), Pulse, and various therapeutic-specific publications. Originally operating as a division of United Business Media (UBM), CMPMedica's assets were eventually divested or rebranded as UBM Medica before being sold to various entities, including M3, Inc. and Cogora.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMPMedica.